Alzheimer's Data Withdrawn

(MedPage Today) -- A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week.
The preprint was posted on Research Square and had not been peer-reviewed, but its findings were publicized...